Navigation Links
Peregrine Pharmaceuticals Reports Financial Results for Fiscal Year 2009
Date:7/14/2009

expansion stage of the trial, which will enroll a total of 46 advanced breast cancer patients overall.
  • Reported that in a Phase II trial evaluating bavituximab in combination with carboplatin and paclitaxel in non-small cell lung cancer (NSCLC) patients with locally advanced or metastatic disease, 11 of 17, or almost 65% of evaluable patients in the initial cohort, achieved an objective tumor response according to RECIST criteria. These early results, which exceeded the pre-specified endpoint needed to expand the trial, compare very favorably with historical data with chemotherapy alone and are especially encouraging in this hard-to-treat cancer. Patient enrollment and dosing are continuing in the expansion stage of the trial, which will enroll a total of 49 NSCLC patients overall.
  • Completed patient enrollment in a Phase I trial evaluating bavituximab as monotherapy in patients with advanced refractory cancers. At the 2009 ASCO Annual Meeting, study researchers reported that bavituximab had demonstrated a predictable pharmacokinetic profile and acceptable safety, and that a maximum tolerated dose was not reached, even at the highest planned dose level.
  • Announced that the ASCO Research Foundation awarded one of its 2009 Career Development Awards to a researcher at the University of Texas Southwestern Medical Center for a study of the biologic effects of bavituximab and chemotherapy in patients with advanced lung cancer.
  • Presented data from two studies at the AACR 2009 Annual Meeting providing further confirmation of the unique immunomodulatory mechanisms contributing to the anti-tumor activity of Peregrine's anti-PS antibody platform.
  • Bavituximab Anti-Viral Program

    The company continued to advance the bavituximab anti-viral program:

    • Received major validation of the broad anti-viral potential of the company's anti-PS antib
      '/>"/>

    SOURCE Peregrine Pharmaceuticals, Inc.
    Copyright©2009 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17

    Related medicine news :

    1. Positive Results From Peregrine Pharmaceuticals Bavituximab Phase l HCV Trial Presented at AASLD Meeting
    2. Peregrine Pharmaceuticals Receives Approval to Begin New Phase II Trial of Bavituximab in Patients With Metastatic Breast Cancer
    3. Peregrine Pharmaceuticals Announces Positive Data From Cotara(R) Brain Cancer Trials
    4. Data Published in Nature Medicine Highlights Ability of Peregrine Pharmaceuticals Bavituximab to Cure Lethal Virus Infections
    5. Peregrine Pharmaceuticals Awarded Broad New U.S. Patent for Anti-Viral Applications of Phospholipid-Targeting Antibodies
    6. Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2009
    7. Peregrine Pharmaceuticals Bavituximab Achieves Primary Endpoint in First Stage of Phase II Breast Cancer Study
    8. Peregrine Pharmaceuticals to Report Third Quarter FY 2009 Financial Results
    9. Peregrine Pharmaceuticals Receives Additional Time to Regain Compliance With NASDAQs Minimum Bid Price Rule
    10. Peregrine Pharmaceuticals Reports Progress in Cotara(R) Brain Cancer Clinical Program
    11. ASCO Research Foundation Grant Will Support Study of Peregrines Bavituximab in Lung Cancer
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:5/27/2015)... Ticket Down is a reputable source for 2015 Cleveland Cavaliers ... during the 2014-15 NBA season and they delighted their fan base ... of 118-88. , For the Cavaliers, this is their ... lost to the San Antonio Spurs. Once Lebron James joined ... it to the NBA finals increased tenfold. The team had ...
    (Date:5/27/2015)... 2015 Hundreds of Risperdal lawsuits ... individuals who allegedly suffered gynecomastia (male breast growth) ... the antipsychotic drug continue to move forward in ... Philadelphia Court of Common Pleas. According to court ... trial program, as the third trial involving Risperdal’s ...
    (Date:5/27/2015)... Allred Dental located in San Marcos, CA came ... extensive dental treatment - understand the oral issues they are ... problems. , Dr. Jeff Allred calls it “Dental Case Planning” ... of the patient’s oral health and problems together with the ... health problems. , “The dental case planning process starts with ...
    (Date:5/27/2015)... Bedford, New Hampshire (PRWEB) May 27, 2015 ... published in the April 2015 issue of the Journal ... of diet sodas and abdominal obesity, Bedford Commons ... consuming water instead of non-nutritive sweetener-flavored beverages. , ... long-term waist circumference, a comprehensive San Antonio Longitudinal Study ...
    (Date:5/27/2015)... (PRWEB) May 27, 2015 Difass USA, ... in the U.S. with its first three flagship products, ... for purchase nationwide through http://www.difassusa.com . , ... health and productivity, but some people struggle with getting ... Dormiva™ is a sleep aid designed to help you ...
    Breaking Medicine News(10 mins):Health News:Cavs NBA Finals Tickets: Ticket Down Slashes Ticket Prices on Cleveland Cavaliers 2015 NBA Finals Tickets at Quicken Loans Arena and Offers Valuable Promo Code 2Health News:Risperdal Lawsuit Attorneys at Bernstein Liebhard LLP Look Forward to Start of Third Gynecomastia Bellwether Trial in Pennsylvania 2Health News:Risperdal Lawsuit Attorneys at Bernstein Liebhard LLP Look Forward to Start of Third Gynecomastia Bellwether Trial in Pennsylvania 3Health News:San Marcos Dentistry Office Offering a New Service Dental Case Planning 2Health News:Recent Study About the Link Between Diet Sodas and Abdominal Fat Reinforces Bedford Commons OB-GYN's Recommendation to Drink Plenty of Water 2Health News:Supplement Brand Difass USA Launches in the U.S. with Three Flagship Products Designed to Bring Balance Back to Your Life 2
    ... Wellcome Fund (BWF) has selected Emory University for a ... scientists whose expertise in research and teaching will bridge ... program is one of three new BWF programs funded ... Based Sciences. The other two programs will be located ...
    ... With millions of baby boomers entering late adulthood, the number ... rise over the next several decades. , A team ... rapid screening test to detect mild cognitive impairment (MCI) ... today in the online edition of Journal of Alzheimer,s ...
    ... Adair Greene-McCann walked off with top,honors at the 2008 ... for Sarna(R), an over-the-counter line of lotions for the relief,of ... , The Gold Award ... in the Over-the-Counter Advertisement/Campaign category, beating,out four other finalists. , ...
    ... A simple and inexpensive,developmental diagnostic assay produced by ... highly accurate for rapid detection,of serious staph bacteria ... The research was reported in three scientific,presentations at ... (ICAAC). , ...
    ... Sciences, a manufacturer and distributor of innovative, cost-effective medical devices, ... NuView System For Non-Gyn Cytology is designed to bring affordable ... ... NASHVILLE, Tenn. (Business Wire EON) November 18, 2008 ...
    ... FOX program “House”) is America’s most loved and ... most would want as their own doctor, according ... of Medical Specialties (ABMS). The survey found that ... capabilities, while at the same time, many respondents ...
    Cached Medicine News:Health News:Burroughs Wellcome Fund award creates new Ph.D. path linking laboratory and population sciences 2Health News:Burroughs Wellcome Fund award creates new Ph.D. path linking laboratory and population sciences 3Health News:New approach to screen individuals for early Alzheimer's disease 2Health News:Adair Greene-McCann Wins Gold with 'Relief' 2Health News:New Research Shows MicroPhage Test Accurately and Rapidly Detects Serious Bacterial Infections 2Health News:New Research Shows MicroPhage Test Accurately and Rapidly Detects Serious Bacterial Infections 3Health News: Consumers Weigh in on Which TV Doc They Would Want as Their Own:Survey Results from the American Board of Medical Specialties Find Dr. House Most Loved/Hated TV Doctor 2Health News: Consumers Weigh in on Which TV Doc They Would Want as Their Own:Survey Results from the American Board of Medical Specialties Find Dr. House Most Loved/Hated TV Doctor 3
    (Date:5/27/2015)... DUBLIN , May 27, 2015 /PRNewswire/ ... ) has announced the addition of the  ...  report to their offering.       ... be divided into to two broad categories ... In US, cancer vaccines belong to both ...
    (Date:5/27/2015)... -- Research and Markets( http://www.researchandmarkets.com/research/ljsxt8/asia_pacific ) has announced the addition ... - Growth, Trends And Forecasts (2014 - 2019)" company ... Pacific market for Portable X-Ray Devices is expected ... X-Ray is a form of electromagnetic radiation which ... bones. The need of point of care diagnostics has led ...
    (Date:5/27/2015)... Research and Markets( http://www.researchandmarkets.com/research/nt9zlx/asia_pacific ) has announced the addition ... Trends And Forecasts (2014 - 2019)" company profile ... type of imaging that customs a low-dose x-ray system ... is used to support in the early detection and ... is a noninvasive medical test that helps physicians analyze ...
    Breaking Medicine Technology:US Cancer Vaccine Market Outlook 2020 2US Cancer Vaccine Market Outlook 2020 3Asia Pacific Portable X Ray Devices Market 2015 - Trends And Forecasts to 2019 2Asia Pacific Mammography Market Trends and Forecasts 2015-2019 2
    ... 27, 2012   Vocollect Healthcare Systems , part of Vocollect, ... IN ), announces that the Homestead of Sherman ... care allows Homestead of Sherman to deliver quality ... reform requirements. , AccuNurse interactive care enables ...
    ... 27, 2012 New Jersey would lose over 2,400 ... denied their choice of pharmacy if the proposed mega-merger ... National Community Pharmacists Association (NCPA) said today. ... merger is stopped, pharmacists fear that virtually everyone in ...
    Cached Medicine Technology:Homestead of Sherman Uses AccuNurse Interactive Care to Improve Care and Service 2Homestead of Sherman Uses AccuNurse Interactive Care to Improve Care and Service 3New Jersey Jobs, Pharmacy Choice Endangered by Proposed Express Scripts-Medco Merger 2New Jersey Jobs, Pharmacy Choice Endangered by Proposed Express Scripts-Medco Merger 3
    SAS Strep A Test is a rapid visual test for the presumptive qualitative detection of Group A Streptococcal antigen from throat swab specimens. Group A streptococcus is the principal cause of respirat...
    HemataSTAT II has a manual reader. It uses both 0.5 and 1.1 ID capillary tubes., , Spins in just 60 seconds , Built-in reader with LCD display , Accuracy comparable to NCCLS reference method , Lid lo...
    ... System has been providing accurate, reliable PT/INR results ... of care. , The CoaguChek System is the ... when monitoring on Coumadin (warfarin sodium) therapy. The ... result from a fingerstick drop (10ul) of whole ...
    ... The ADC drugs of abuse tests are highly ... the SAMHSA recommended cut-off as confirmed by GC/MS ... A more specific alternative method (such as GC/MS) ... confirmed result. Professional judgment should be applied to ...
    Medicine Products: